Similarly, recent studies have also found that decitabine could reactivate the expression of Syk in breast cancer and nasopharyngeal cancer cells.23, 24 The supplement of decitabine also affected the invasiveness of breast cancer cells.23 Here, SYK is linked to breast carcinoma.